Mumbai-based pharmaceutical major Lupin will acquire Netherlands-based VISUfarma B.V. for an enterprise value of EUR 190 million (about Rs 2,000 crore) through its wholly owned subsidiary Nanomi B.V., ...

Many small companies are trying to push through; however, their plans do not convince the VCs looking for ten times growth in five to eight years, writes Amit Chaurasia In the recent Operation Sindoor ...